SENSEX NIFTY
You are here : Moneycontrol > Mutual Funds > Sector - Pharma & Healthcare > SBI Mutual Fund > SBI Pharma Fund (G)

SBI Pharma Fund (G)

PLAN: Regular OPTIONS: Growth
116.839 0.24 (0.21%)

NAV as on 25 Nov, 2014

CRISIL MF RANK

Not Ranked

Scheme Risk Grade

  HIGH RISK

HIGH RISK

  • For investors looking at long term capital growth investments.
  • Ideal for people who wish to benefit from potentially higher returns and have the risk appetite for the same.
FUND FAMILY : SBI Mutual Fund FUND CLASS : Sector - Pharma & Healthcare
OR
Add to Watchist
Have you invested in these stocks? You can track them better in your Portfolio
Holdings (Oct 31, 14)
Equity Sector Value
(Rs cr)
Assets %
Sun Pharma Pharmaceuticals 82.86 25.14
Lupin Pharmaceuticals 39.70 12.04
Dr Reddys Labs Pharmaceuticals 36.68 11.13
Aurobindo Pharm Pharmaceuticals 25.19 7.64
Ranbaxy Labs Pharmaceuticals 23.70 7.19
Divis Labs Pharmaceuticals 22.46 6.81
Cadila Health Pharmaceuticals 18.22 5.53
Torrent Pharma Pharmaceuticals 14.15 4.29
Strides Arcolab Pharmaceuticals 13.33 4.05
Natco Pharma Pharmaceuticals 9.34 2.83
Sector Allocation (Oct 31, 14)
  Sector   % 1-Year
High Low

Pharmaceuticals

99.20 99.20 96.68
Asset Allocation (%) (Oct 31, 14)
Class
%

Equity

99.20

Others / Unlisted

0.00

Debt

0.00

Mutual Funds

N.A

Money Market

0.87

Cash / Call

-0.07

Net Receivable / Payable

N.A
Concentration
Holdings
%

Top 5

63.14

Top 10

86.65
Sectors
%

Top 3

99.20
Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.